Alias LedgerIboga nomenclature
HomeIboga Alkaloids
Relatives, not synonyms

The iboga alkaloids

These molecules share ibogaine’s chemical family and much of its conversation — but they are distinct compounds, and treating them as the same name is a common error.

The iboga root bark is a chemical community, not a single ingredient. Ibogaine is the headline alkaloid, but it sits among close relatives — some naturally occurring, some engineered in a lab to keep the benefits while shedding the risks. The most important one to know is noribogaine, the metabolite your body makes from ibogaine, which lingers far longer and is thought to do much of the lasting work.

Noribogaine is also where the naming gets commercially specific: it has been advanced under the development code DMX-1001 and studied for alcohol use disorder. If you have read about ibogaine treatment for alcohol use, the compound in the frame is often noribogaine or standardised ibogaine HCl rather than raw plant material — another reason the exact name matters.

Major metabolite

Noribogaine

12-hydroxyibogamine

The main active breakdown product of ibogaine, with a far longer half-life; thought to carry much of the sustained effect. Developed separately as DMX-1001.

Parent skeleton

Ibogamine

CAS 481-87-8

The core iboga scaffold without the 12-methoxy group — ibogaine is literally “12-methoxy-ibogamine.”

Congeners

Ibogaline & Tabernanthine

root-bark alkaloids

Naturally co-occurring alkaloids in iboga root bark, part of the mixture in whole-plant preparations.

Related alkaloids

Coronaridine & Voacangine

Voacanga africana

Iboga-type alkaloids from related plants; voacangine is a common semi-synthetic starting point for ibogaine.

Synthetic analogue

18-Methoxycoronaridine

18-MC

Engineered to keep anti-addictive activity while reducing the cardiac liability linked to ibogaine.

Designed scaffold

Ibogalog & simplified analogues

non-classical scaffolds

Simplified, often non-hallucinogenic molecules inspired by ibogaine’s shape.

Why “analogue” is not “alias”

Molecules like 18-MC and the newer “ibogalog” scaffolds are deliberately different from ibogaine. They are designed to isolate specific effects — anti-addictive action — while dialling down the long hallucinogenic experience and the cardiac risk. Calling them “ibogaine” misstates both what they are and what they do.

The safest habit: treat each name as pointing at exactly one compound, and check whether a claim is about ibogaine, its metabolite, a plant congener, or a synthetic analogue.